SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4bn5'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FSL_B_NIOB145_1
(LEGHEMOGLOBIN A)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 8 PHE A 251
ILE A 230
PHE A 180
PHE A 293
 None
SR7  A1396 (-4.8A)
SR7  A1396 (-3.7A)
None
 0.75A 1fslB-4bn5A:
undetectable		 1fslB-4bn5A:
19.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N13_D_AG2D7015_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 7 LEU A 322
LEU A 315
LEU A 318
GLY A 319
 None
None
None
CNA  A1395 (-3.9A)
 0.80A 1n13D-4bn5A:
undetectable
1n13E-4bn5A:
undetectable		 1n13D-4bn5A:
17.02
1n13E-4bn5A:
12.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ONI_I_BEZI517_0
(14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 7 ILE A 268
PRO A 289
PHE A 192
ALA A 196
 None
 1.11A 1oniG-4bn5A:
undetectable
1oniI-4bn5A:
undetectable		 1oniG-4bn5A:
19.35
1oniI-4bn5A:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XLX_A_CIOA101_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		5 / 12 LEU A 347
ASN A 344
THR A 320
ILE A 317
MET A 143
 None
CNA  A1395 (-3.3A)
CNA  A1395 (-4.2A)
None
None
 1.45A 1xlxA-4bn5A:
undetectable		 1xlxA-4bn5A:
19.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1YC2_A_NCAA506_0
(NAD-DEPENDENT
DEACETYLASE 2)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		5 / 6 ALA A 146
SER A 149
ASN A 229
ILE A 230
ASP A 231
 CNA  A1395 (-3.1A)
CNA  A1395 (-4.3A)
CNA  A1395 (-3.7A)
SR7  A1396 (-4.8A)
CNA  A1395 (-3.5A)
 0.40A 1yc2A-4bn5A:
20.9		 1yc2A-4bn5A:
31.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1YC2_D_NCAD510_0
(NAD-DEPENDENT
DEACETYLASE 2)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 5 ALA A 146
ASN A 229
ILE A 230
ASP A 231
 CNA  A1395 (-3.1A)
CNA  A1395 (-3.7A)
SR7  A1396 (-4.8A)
CNA  A1395 (-3.5A)
 0.34A 1yc2D-4bn5A:
20.6		 1yc2D-4bn5A:
31.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1YC2_E_NCAE507_0
(NAD-DEPENDENT
DEACETYLASE 2)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 7 ILE A 154
ASN A 229
ILE A 230
ASP A 231
 CNA  A1395 (-3.8A)
CNA  A1395 (-3.7A)
SR7  A1396 (-4.8A)
CNA  A1395 (-3.5A)
 0.40A 1yc2E-4bn5A:
20.8		 1yc2E-4bn5A:
31.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1YC5_A_NCAA2001_0
(NAD-DEPENDENT
DEACETYLASE)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		5 / 7 ALA A 146
SER A 149
ASN A 229
ILE A 230
ASP A 231
 CNA  A1395 (-3.1A)
CNA  A1395 (-4.3A)
CNA  A1395 (-3.7A)
SR7  A1396 (-4.8A)
CNA  A1395 (-3.5A)
 0.37A 1yc5A-4bn5A:
24.6		 1yc5A-4bn5A:
36.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1YC5_A_NCAA2001_0
(NAD-DEPENDENT
DEACETYLASE)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		5 / 7 ALA A 146
SER A 149
ILE A 154
ASN A 229
ASP A 231
 CNA  A1395 (-3.1A)
CNA  A1395 (-4.3A)
CNA  A1395 (-3.8A)
CNA  A1395 (-3.7A)
CNA  A1395 (-3.5A)
 0.39A 1yc5A-4bn5A:
24.6		 1yc5A-4bn5A:
36.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2H4J_A_NCAA1002_0
(NAD-DEPENDENT
DEACETYLASE)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		5 / 5 ALA A 146
ILE A 154
ASN A 229
ILE A 230
ASP A 231
 CNA  A1395 (-3.1A)
CNA  A1395 (-3.8A)
CNA  A1395 (-3.7A)
SR7  A1396 (-4.8A)
CNA  A1395 (-3.5A)
 0.55A 2h4jA-4bn5A:
24.8		 2h4jA-4bn5A:
36.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QL8_B_BEZB143_0
(PUTATIVE REDOX
PROTEIN)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 6 ARG A 224
ALA A 241
ARG A 301
PRO A 299
 None
 1.35A 2ql8A-4bn5A:
undetectable
2ql8B-4bn5A:
undetectable		 2ql8A-4bn5A:
21.69
2ql8B-4bn5A:
21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W67_C_VIVC301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		5 / 12 VAL A 208
LEU A 213
ILE A 343
LEU A 341
VAL A 128
 None
 1.10A 3w67C-4bn5A:
undetectable		 3w67C-4bn5A:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W68_A_VIVA301_0
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		5 / 12 VAL A 208
LEU A 213
ILE A 343
LEU A 341
VAL A 128
 None
 1.19A 3w68A-4bn5A:
undetectable		 3w68A-4bn5A:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WEO_A_ACRA1001_1
(ALPHA-GLUCOSIDASE)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		5 / 12 PHE A 294
ILE A 154
ASP A 156
ARG A 158
PHE A 180
 SR7  A1396 (-3.5A)
CNA  A1395 (-3.8A)
SR7  A1396 ( 3.6A)
CNA  A1395 ( 3.6A)
SR7  A1396 (-3.7A)
 1.31A 3weoA-4bn5A:
undetectable		 3weoA-4bn5A:
15.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BBO_C_ACTC1113_0
(BLR5658 PROTEIN)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 4 ASN A 229
ALA A 146
GLY A 145
THR A 320
 CNA  A1395 (-3.7A)
CNA  A1395 (-3.1A)
CNA  A1395 ( 3.7A)
CNA  A1395 (-4.2A)
 1.38A 4bboC-4bn5A:
undetectable		 4bboC-4bn5A:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DX7_B_DM2B1104_1
(ACRIFLAVINE
RESISTANCE PROTEIN B)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		5 / 8 GLU A 296
PHE A 251
ILE A 268
VAL A 272
PHE A 193
 None
 1.25A 4dx7B-4bn5A:
undetectable		 4dx7B-4bn5A:
13.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4O8Z_A_BBIA402_1
(NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 5 PHE A 180
HIS A 248
LEU A 298
PRO A 326
 SR7  A1396 (-3.7A)
SR7  A1396 ( 3.5A)
None
None
 0.76A 4o8zA-4bn5A:
39.1		 4o8zA-4bn5A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4O8Z_A_BBIA402_1
(NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 5 PHE A 180
HIS A 248
PHE A 294
LEU A 298
 SR7  A1396 (-3.7A)
SR7  A1396 ( 3.5A)
SR7  A1396 (-3.5A)
None
 0.60A 4o8zA-4bn5A:
39.1		 4o8zA-4bn5A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RMJ_A_NCAA402_0
(NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-2)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 7 ILE A 154
ASN A 229
ILE A 230
ASP A 231
 CNA  A1395 (-3.8A)
CNA  A1395 (-3.7A)
SR7  A1396 (-4.8A)
CNA  A1395 (-3.5A)
 0.37A 4rmjA-4bn5A:
32.6		 4rmjA-4bn5A:
49.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WQ4_B_ACTB403_0
(TRNA N6-ADENOSINE
THREONYLCARBAMOYLTRA
NSFERASE)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		3 / 3 ARG A 358
ASP A 359
ARG A 340
 None
 0.60A 4wq4B-4bn5A:
undetectable		 4wq4B-4bn5A:
22.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5H4D_A_BBIA403_1
(NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 6 GLU A 177
PHE A 294
GLU A 323
VAL A 324
 SR7  A1396 (-4.4A)
SR7  A1396 (-3.5A)
None
None
 1.35A 5h4dA-4bn5A:
17.5		 5h4dA-4bn5A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5H4D_A_BBIA403_1
(NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 6 PHE A 157
GLU A 177
PHE A 294
VAL A 324
 SR7  A1396 (-3.7A)
SR7  A1396 (-4.4A)
SR7  A1396 (-3.5A)
None
 1.32A 5h4dA-4bn5A:
17.5		 5h4dA-4bn5A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HS1_A_VORA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)		 4bn5 NAD-DEPENDENT
PROTEIN DEACETYLASE
SIRTUIN-3,
MITOCHONDRIAL
(Homo
sapiens) 		4 / 8 PHE A 327
GLY A 145
LEU A 225
LEU A 244
 None
CNA  A1395 ( 3.7A)
None
None
 0.81A 5hs1A-4bn5A:
undetectable		 5hs1A-4bn5A:
20.53